Previous biochemical studies suggested that HIV-1-encoded Vpr may kill cells through an effect on the adenine nucleotide translocase (ANT), thereby causing mitochondrial membrane permeabilization (MMP). Here, we show that Vpr fails to activate caspases in conditions in which it induces cell killing. The knock-out of essential caspase-activators (Apaf-1 or caspase-9) or the knock-out of a mitochondrial caspaseindependent death effector (AIF) does not abolish Vprmediated killing. In contrast, the cytotoxic effects of Vpr are reduced by transfection-enforced overexpression of two MMP-inhibitors, namely the endogenous protein Bcl-2 or the cytomegalovirus-encoded ANT-targeted protein vMIA. Vpr, which can elicit MMP through a direct effect on mitochondria, and HIV-1-Env, which causes MMP through an indirect pathway, exhibit additive (but not synergic) cytotoxic effects. In conclusion, it appears that Vpr induces apoptosis through a caspase-independent mitochondrial pathway.
Introduction
HIV-1 encodes several apoptosis inducing proteins, including the envelope glycoprotein complex (Env) and accessory proteins such as Tat, Nef, Vpu, and Vpr. 1 ± 3 Vpr, which is present in virions as well as in infected cells, has the particularity to be secreted into culture supernatants (in vitro) or body fluids such as serum and cerebrospinal liquid (in vivo). The Vpr protein can penetrate into non-infected bystander cells. Upon addition to cell cultures, it exerts pleiotropic effects including an arrest in the G2 phase of the cell cycle, 4, 5 inhibition of activation-induced T cell death, 6, 7 and induction of apoptosis in a wide range of cell types. 5,7 ± 11 When expressed as a transgene in mice, it causes a lymphocyte depletion linked to an excess of apoptosis, suggesting that its proapoptotic action prevails in vivo. 12 Similarly, co-expression of Vpr with a DNA vaccine reveals its immunosuppressive potential in vivo. 13 The intact Vpr protein of 96 amino acids as well as its Cterminal moiety (Vpr 52-96, but not its N-terminus Vpr 1-51) can trigger apoptosis through a pathway which involves mitochondrial membrane permeabilization (MMP).
14 Experiments conducted on isolated mitochondria or on model membranes indicate that Vpr can trigger MMP through its capacity to interact with the adenine nucleotide translocase (ANT), thereby creating a composite ion channel within the inner mitochondrial membrane whose opening results into the dissipation of the mitochondrial transmembrane potential (DC m ), followed by permeabilization of the outer mitochondrial membrane with consequent release of soluble intermembrane proteins (SIMPs). 15 Apoptogenic SIMPs include apoptosis inducing factor (AIF), a flavoprotein which translocates to the nucleus where it activates a sessile DNase, 16, 17 and cytochrome c, a heme protein which translocates to the cytosol where it interacts with Apaf-1 and pro-caspase-9 to create the apoptosome, the caspase activation complex. 18 Based on the above premises, we comparatively evaluated the role of MMP, caspase activation and AIF in Vpr-induced cell death. To this end, we tested the effect of Vpr 52-96 on cells in which the AIF, caspase-9 or Apaf-1 genes had been invalidated by homologous recombination. Moreover, we determined the effect of Vpr on cells expressing MMP-inhibitory molecules such as Bcl-2 or the viral mitochondrial inhibitor of apoptosis (vMIA), as well as on cells in which the mitochondrial pathway leading to apoptosis is stimulated by another HIV-1 gene product, namely the envelope (Env) glycoprotein complex. Collectively, our data reveal MMP to be a critical step for Vpr-induced killing, while caspase activation and AIF appear to be dispensable for the cytotoxic action of Vpr.
Results and Discussion
Caspase activation and AIF are dispensable for Vpr-induced cell killing
To determine to which degree caspases and AIF contribute to Vpr-mediated killing, synthetic Vpr 52-96 peptide 19 was added to mouse embryonic stem (ES) cells with a normal genotype (Wt) or cells in which either of two essential apoptosome components (Apaf-1 or caspase-9) 20, 21 or, alternatively, AIF had been invalidated by homologous recombination. 17 Vpr 52-96 caused a DC m loss (measured by means of the DC m -sensitive fluorochrome 3,3'dihexyloxacarbocyanine iodide, DiOC 6 (3), followed by cytofluorometric analysis) as well as a loss of viability (determined by measuring the incorporation of the vital dye propidium iodide, PI) 22 ( Figure 1A ). The loss of DC m and viability were indistinguishable in Wt, Apaf-1
, caspase-9 7/7 ; or AIF 7/y ES cells ( Figure 1A ), both as far as the dose response ( Figure  1B ) and the kinetics (not shown) of the cell death process were concerned. Moreover, the combined inhibition of caspase-activation (by addition of the pan-caspase inhibitor Z-VAD.fmk) and the knock-out of AIF did not affect the cytotoxic effect of Vpr ( Figure 1A, activation. These differences can probably be attributed to the distinct experimental design (transfection versus addition of the peptide). Since Vpr fails to induce caspase activation, it may be argued that it induces a non-apoptotic cell death. However, we found that Vpr did induce some hallmarks of apoptosis (as opposed to necrosis), in particular pyknosis and chromatin condensation (see below). It thus induces caspaseindependent cell death with some features of apoptosis.
vMIA from cytomegalovirus (CMV) and Bcl-2 inhibit Vpr-induced MMP and cell killing
Bcl-2 and vMIA represent two proteins with MMP-inhibitory properties. Bcl-2 is found inserted in intracellular membranes (in particular the endoplasmic reticulum and the outer mitochondrial membrane) and stabilizes the mitochondrial membrane barrier function by local interactions with pore forming proteins contained in the permeability transition pore complex, namely ANT, voltage-dependent anion channel (VDAC), and pro-apoptotic Bcl-2 family members. 25 ± 28 Viral mitochondrial inhibitor of apoptosis (vMIA or UL37) is encoded by CMV and is exclusively found in mitochondrial membranes, where it specifically interacts with ANT but not with VDAC. 29 ± 32 Both vMIA and Bcl-2 inhibited the DC m dissipation induced by Vpr 52-96, as determined by two different DC m -sensitive fluorochromes, DiOC 6 (3) (Figure 3A ,C) and 5,5',6,6'-tetrachloro-1,1', 3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1, which undergoes a red ± green shift in the emission spectrum when the DC m drops) ( Figure 3B ). vMIA also largely reduced the Vpr 52-96-stimulated increase in the production of rective oxygen species (ROS, measured by means of the ROS-induced conversion of non-fluorescent hydroethidine into fluorescent ethidium 33 ) (Figure 3A ), the translocation of cytochrome c to the cytosol ( Figure 4A ), as well as the translocation of AIF from mitochondria to the Figure 4B ), as determined by in situ immunofluorescence. 34 Concomitantly, vMIA reduced the frequency of cells exhibiting an apoptotic chromatin condensation, as determined by staining with the chromatin dye Hoechst 33342 ( Figure 4C ). These results confirm that MMP induction, presumably mediated by a direct effect of Vpr on ANT (which is antagonized by vMIA) is a decisive step in Vpr-induced cytotoxicity.
Additive cytotoxic effects of Vpr and Env
When cells expressing lymphotropic HIV-1 Env are cocultured with cells expressing a suitable combination of the Env receptor CD4 and the co-receptor CXCR4, syncytia are formed, as this can be detected by pre-staining individual cells with non-toxic dyes (CellTracker 1 green CMFDA for HeLa Env cells and CellTracker 1 blue CMAC for HeLa CD4 cells), followed by FACS detection of double-stained fusion products ( Figure 5A ). We have previously found that Env-elicited syncytia undergo apoptosis in an MMP-dependent fashion, through a pathway which involves the transcriptional upregulation of p53 target genes including that of the MMP-inducing Bcl-2 antagonist Bax. 35 ± 37 This pathway is also activated in primary lymphoblasts infected by HIV-1.
37 ± 39 Based on the observation, that a ternary ANT/Bax/Vpr complex permeabilizes membranes more efficiently than ANT/Vpr, 15 we suspected that Env-elicited syncytia (which upregulate Bax, as mentioned above) might be more susceptible to Vpr 52-96-induced MMP and killing than control cells. However, Vpr caused a loss of viability (positive PI staining) in freshly formed syncytia (24 h of coculture) and individual cells with a similar efficacy ( Figure 5A ). Moreover, careful dose response studies revealed no difference in the Vpr 52-96-induced DC m dissipation (determined by means of the DC m -sensitive dye JC-1, as described in reference 36) and chromatin condensation (determined by staining with Hoechst 33342) between individual cells and syncytia, even in an aging (48 h) syncytial population in which a significant portion of cells is undergoing apoptosis ( Figure  5B ). In conclusion, Vpr and Env exert additive rather than synergic cytotoxic effects. 
Concluding remarks
The data shown here provide genetic evidence that Vpr kills cells through a pathway that does not rely on caspases or AIF, yet involves MMP as a critical step. That MMP is involved in cell killing by Vpr is suggested by the fact that it is inhibited by Bcl-2, a protein thought to mediate apoptosis inhibition via local effects on mitochondria, 40 ± 42 although local effects on the endoplasmic reticulum have also been reported. 43 ± 46 More convincingly, vMIA, an apoptosis inhibitor exclusively targeted to mitochondria, 29 antagonizes Vpr-induced cell killing. In contrast, it appears that the absence of AIF or that of essential ingredients of the post-mitochondrial caspase activation machinery (Apaf-1, caspase-9) has no incidence on Vpr-mediated cytotoxicity. Speculatively, the MMP-associated bioenergetic catastrophe could suffice to cause cell death, 47 without that catabolic hydrolases (apoptosomeelicited caspases and AIF-elicited nucleases) would be required for the execution of the cell death program. It appears particularly intriguing that vMIA from CMV, which targets ANT to inhibit apoptosis, 29 can antagonize the cytotoxicity of HIV-1 Vpr, which targets ANT to induce apoptosis. 15 Whether these effects involve a competition for ANT binding between the two antagonistic viral proteins (vMIA and Vpr) and whether they are relevant for the pathogenesis of simultaneous HIV-1/CMV infections remains to be elucidated. Nonetheless, the fact that several viruses have developed independent strategies to modulate apoptosis by targeting ANT 30 underlines the probable importance of ANT (or ANT-associated proteins) for the regulation of cell death.
Although Env and Vpr both induce apoptosis through induction of MMP, Vpr in a direct fashion 14, 15 and Env in an indirect (p53-dependent) pathway, 36, 37, 48, 49 the two proteins do not exhibit a synergistic action of apoptosis induction, at least in the model that we studied. As a possibility, Env and Vpr may cooperate in the pathophysiology of HIV-1 infection by inducing apoptosis in different cellular populations rather than by cooperating within the same cell. Irrespective of these possibilities, our data underline the general importance of MMP for the cytotoxic effects mediated by HIV-1-encoded proteins.
Materials and Methods
Cell lines, culture conditions, and Vpr treatment Embryonic stem (ES) stells (wild type, Apaf-1 7/7 , caspase-9 7/7 or AIF 7/y ) were maintained in the presence of leukemia-inhibitory factor, as described. 17, 20, 21 HeLa cells transfected with the cytomegalovirus UL37 exon 1 gene coding for vMIA and with the human Bcl-2 and Bcl-X L gene (kindly provided by Dr. V Goldmacher), 29 as well as control 19,50 as described. 51 In some experiments, the pan-caspase inhibitor Nbenzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD.fmk, 100 mM, Enzyme Systems) was added to the cultures.
Determination of apoptosis-associated parameters
The following fluorochromes were employed to assess apoptosisassociated changes by cytofluorometry on a FACS Vantage (Becton Dickonson), while gating the forward and the side scatters on viable cells: 3,3' dihexyloxacarbocyanine iodide (DiOC 6 (3), 20 nM) for Dc m quantification; propidium iodide (PI, 1 mg/ml) for the determination cell viability; hydroethidine (HE, 1 mM) for the assessment of superoxide anion production. 33 Alternatively, cells cultured on a cover slip were stained with 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1, 3 mM, Molecular Probes) and Hoechst 33342 (2 mM, Sigma), followed by fluorescence microscopic assessment of apoptotic parameters. 34, 36 Cells were fixed on paraformaldehyde (4% w : v) and picric acid (0. 
Generation and evaluation of Env-dependent syncytia
HeLa cells transfected with the Env gene of HIV-1 LAI (HeLa Env) and HeLa cells transfected with CD4 (HeLa CD4) were cultured together (1 : 1 ratio) to generate syncytia, as described. 36, 52, 53 Prior to coculture, HeLa Env cells were pre-stained with 15 mM of CellTracker 1 green CMFDA and HeLa CD4 cells pre-stained with 15 mM CellTracker 1 blue CMAC (7-amino-4-chloromethylcoumarin, both from Molecular Probes). Preliminary experiments showed that neither of these dyes had toxic effects on HeLa cells during a 72 h culture period. After 24 or 48 h of co-culture, cells were treated with the indicated dose of Vpr, stained with PI (1 uM, 15 min), and subjected to FACS analysis. Alternatively, syncytia were stained with JC-1 and Hoechst 33324 and subjected to fluorescence microscopic examination, as described. 36, 48 
